Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment

Published:2018-04 Issue:3 Volume:14 Page:863-873
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Gowda Raghavendra,Dinavahi Saketh S.,Iyer Soumya,Banerjee Shubhadeep,Neves Rogerio I.,Pameijer Colette R.,Robertson Gavin P.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference52 articles.

1. BRAF inhibitors and melanoma;Flaherty;Cancer J,2011

2. Intermittent dosing with vemurafenib in BRAF V600E-mutant melanoma: review of a case series;Dooley;Ther Adv Med Oncol,2014

3. Inhibition of phospholipase A2-mediated arachidonic acid release by cyclic AMP defines a negative feedback loop for P2Y receptor activation in Madin-Darby canine kidney D1 cells;Xing;J Biol Chem,1999

4. Cancer-related inflammation;Mantovani;Nature,2008

5. Inflammation and cancer;Coussens;Nature,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanotechnology and Phytochemicals in Anticancer Therapy;Pharmaceutics;2024-09-05

2. Deep learning classification of uveal melanoma based on histopathological images and identification of a novel indicator for prognosis of patients;Biological Procedures Online;2023-06-02

3. Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma;Advanced Pharmaceutical Bulletin;2023-01-23

4. Phospholipases as pivotal players in signal transduction during tumorigenic processes;Phospholipases in Physiology and Pathology;2023

5. Phospholipase signaling network in cancer metastasis and chemoresistance;Phospholipases in Physiology and Pathology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3